Picture of Osteopore logo

OSX Osteopore Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Osteopore, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-2.38-1.95-3.62-4.2-4.83
Depreciation
Amortisation
Non-Cash Items0.830.110.1170.0040.546
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.269-0.088-0.528-0.020.081
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1.75-1.76-3.81-3.99-3.74
Capital Expenditures-0.08-0.381-0.195-0.064-0.007
Purchase of Fixed Assets
Other Investing Cash Flow Items0.4860
Sale of Business
Cash from Investing Activities0.406-0.381-0.195-0.064-0.007
Financing Cash Flow Items-0.242-0.5630
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.647.84-0.4860.8963.58
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.295.73-4.5-3.2-0.219